Oxurion Announces Extraordinary General Shareholders’ Meeting
05 6월 2024 - 2:00AM
Oxurion Announces Extraordinary General Shareholders’ Meeting
Oxurion Announces Extraordinary General
Shareholders’ Meeting
Leuven, BELGIUM – June 4, 2024 – 07:00
PM CET – Oxurion NV (Euronext Brussels: OXUR), a
biopharmaceutical company headquartered in Leuven, announces an
extraordinary general shareholders’ meeting to be held on Thursday
July 4, 2024 at 11:00 AM (CET).
This extraordinary general shareholders’ meeting
regards the proposal of share consolidation in respect of all
outstanding shares of the Company by means of a 1-for-10,000 share
consolidation.
The convening notice and other documents
pertaining to the shareholders’ meeting, can be consulted on
Oxurion’s website Oxurion/shareholders.
About Oxurion
Oxurion (Euronext Brussels: OXUR) is engaged in
developing next-generation standard of care ophthalmic therapies
for the treatment of retinal disease. Oxurion is based in Leuven,
Belgium. More information is available at www.oxurion.com.
Please contact for additional information:
Oxurion NVPascal GhosonChief Executive
Officerpascal.ghoson@oxurion.com |
Backstage CommunicationJurgen
VluijmansPartnerjurgen@backstagecom.be |
Oxurion Nv (LSE:0G99)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Oxurion Nv (LSE:0G99)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024